Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1995 1
1997 2
1999 1
2000 2
2001 3
2002 1
2003 3
2004 1
2005 2
2006 4
2007 1
2008 1
2009 6
2010 5
2011 4
2012 4
2013 5
2014 8
2015 10
2016 6
2017 8
2018 4
2019 10
2020 12
2021 15
2022 15
2023 12
2024 7
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Yasuda S, et al. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. N Engl J Med. 2019. PMID: 31475793 Clinical Trial.
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, Miyamoto Y, Saito Y; Japanese Registry of Fulminant Myocarditis Investigators. Kanaoka K, et al. Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27. Circulation. 2022. PMID: 36164974
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
Fibroblast Growth Factors in Cardiovascular Disease.
Morita H, Hoshiga M. Morita H, et al. Among authors: hoshiga m. J Atheroscler Thromb. 2024 Nov 1;31(11):1496-1511. doi: 10.5551/jat.RV22025. Epub 2024 Aug 22. J Atheroscler Thromb. 2024. PMID: 39168622 Free PMC article. Review.
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers.
Sasaki S, Ota K, Sanomura M, Mori Y, Tanaka H, Hakoda A, Sugawara N, Iwatsubo T, Hirata Y, Kakimoto K, Morita H, Nagamatsu W, Hoshiga M, Takeuchi T, Higuchi K, Nishikawa H. Sasaki S, et al. Among authors: hoshiga m. BMC Gastroenterol. 2024 May 21;24(1):177. doi: 10.1186/s12876-024-03269-w. BMC Gastroenterol. 2024. PMID: 38773435 Free PMC article.
Salivary Microbiota Associated with Peripheral Microvascular Endothelial Dysfunction.
Kato-Kogoe N, Kamiya K, Sakaguchi S, Omori M, Komori E, Kudo A, Nakamura S, Nakano T, Ueno T, Tamaki J, Hoshiga M. Kato-Kogoe N, et al. Among authors: hoshiga m. J Atheroscler Thromb. 2023 Jul 1;30(7):820-833. doi: 10.5551/jat.63681. Epub 2022 Sep 22. J Atheroscler Thromb. 2023. PMID: 36130883 Free PMC article.
Hypoplastic Left Atrial Appendage: A Case Report and Literature Review.
Hasegawa H, Ito T, Hourai R, Akamatsu K, Nomura Y, Miyamura M, Fujita SI, Hoshiga M. Hasegawa H, et al. Among authors: hoshiga m. Am J Case Rep. 2021 Oct 18;22:e933260. doi: 10.12659/AJCR.933260. Am J Case Rep. 2021. PMID: 34657932 Free PMC article. Review.
127 results